Literature DB >> 18450056

Survival analysis.

Hongyu Jiang1, Jason P Fine.   

Abstract

This chapter introduces some fundamental results in survival analysis. We first describe what is censored failure time data and how to interpret the failure time distribution. Two nonparametric methods for estimating the survival curve, the life table estimator and the Kaplan-Meier estimator, are demonstrated. We then discuss the two-sample problem and the usage of the log-rank test for comparing survival distributions between groups. Lastly, we discuss in some detail the proportional hazards model, which is a semiparametric regression model specifically developed for censored data. All methods are illustrated with artificial or real data sets.

Mesh:

Substances:

Year:  2007        PMID: 18450056     DOI: 10.1007/978-1-59745-530-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis.

Authors:  Benjamin J Grady; Marylyn D Ritchie
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-03-01

2.  Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic.

Authors:  Vladimir M Kushnir; Ilke Nalbantoglu; Rao Watson; Jonathan Goodwin; Elyas Safar; Reena V Chokshi; Riad R Azar; Nicholas O Davidson
Journal:  Dig Dis Sci       Date:  2014-06-13       Impact factor: 3.199

3.  Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies.

Authors:  Rajul K Jain; David S Hong; Aung Naing; Jennifer Wheler; Thorunn Helgason; Nai-Yi Shi; Yash Gad; Razelle Kurzrock
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse.

Authors:  Rajul K Jain; J Jack Lee; David Hong; Maurie Markman; Jing Gong; Aung Naing; Jennifer Wheler; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

5.  Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies.

Authors:  Rajul K Jain; J Jack Lee; Chaan Ng; David Hong; Jing Gong; Aung Naing; Jennifer Wheler; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

6.  Methods to Determine the Role of Autophagy Proteins in C. elegans Aging.

Authors:  Sivan Henis-Korenblit; Alicia Meléndez
Journal:  Methods Mol Biol       Date:  2019

7.  Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.

Authors:  Yi-Yuan Dong; Chun Xiang; Jian-Xun Lu; Yi-Xin Su; Yu-Fei Pan; Rui Cai; Rong-Jun Zhang; Zhuo-Kai He; Mei-Lian Liu; Hui Huang; Xue Bai; Hua-Ying Tang; Yun-Hua Shi; Yan Wang; Wei Jiang
Journal:  Strahlenther Onkol       Date:  2016-05-23       Impact factor: 3.621

8.  Risk Assessment of Pulmonary Metastasis for Cervical Cancer Patients by Ensemble Learning Models: A Large Population Based Real-World Study.

Authors:  Menglin Zhu; Bo Wang; Tiejun Wang; Yilin Chen; Du He
Journal:  Int J Gen Med       Date:  2021-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.